Gemcitabine treatment for advanced biliary tract cancers

被引：0
|
作者：
Fujita, Tsunenori
Ajiki, Tetsuo
Matsumoto, Ippei
Hirata, Kenro
Takase, Shiro
Kamigaki, Takashi
Shinzeki, Makoto
Fujino, Yasuhiro
Kuroda, Yeshikazu
Ku, Yonson
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A202 / A202
页数：1
相关论文
共 50 条
  • [1] Gemcitabine in advanced biliary tract cancers
    Pasetto, Lara Maria
    Andrea, Mario Rosario D'
    Falci, Cristina
    Monfardini, Silvio
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 61 (03) : 230 - 242
  • [2] Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers
    Verderame, F.
    Russo, A.
    Di Leo, R.
    Badalamenti, G.
    Santangelo, D.
    Cicero, G.
    Valerio, M. R.
    Gulotta, G.
    Tomasello, G.
    Gebbia, N.
    Fulfaro, F.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : VII68 - VII72
  • [3] Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study
    Park, JS
    Oh, SY
    Kim, SH
    Kwon, HC
    Kim, JS
    Hyo, JK
    Kim, YH
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (02) : 68 - 73
  • [4] Gemcitabine, oxaliplatin, and bevacizumab (GEMOX-B): A promising regimen for the treatment of advanced biliary tract cancers
    Mahipal, A.
    Rosato, E.
    Littman, S. J.
    Hargrove, H.
    Bapat, A. R.
    Doria, C.
    Mitchell, E. P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [5] Toward Personalized Treatment of Advanced Biliary Tract Cancers
    Geynisman, Daniel M.
    Catenacci, Daniel V. T.
    [J]. DISCOVERY MEDICINE, 2012, 14 (74) : 41 - 57
  • [6] Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial
    Shroff, Rachna T.
    Javle, Milind M.
    Xiao, Lianchun
    Kaseb, Ahmed O.
    Varadhachary, Gauri R.
    Wolff, Robert A.
    Raghav, Kanwal P. S.
    Iwasaki, Michiko
    Masci, Peter
    Ramanathan, Ramesh K.
    Ahn, Daniel H.
    Bekaii-Saab, Tanios S.
    Borad, Mitesh J.
    [J]. JAMA ONCOLOGY, 2019, 5 (06) : 824 - 830
  • [7] Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review
    Fiteni, Frederic
    Nguyen, Thierry
    Vernerey, Dewi
    Paillard, Marie-Justine
    Kim, Stefano
    Demarchi, Martin
    Fein, Francine
    Borg, Christophe
    Bonnetain, Franck
    Pivot, Xavier
    [J]. CANCER MEDICINE, 2014, 3 (06): : 1502 - 1511
  • [8] Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine
    Ikeda, Masafumi
    Ioka, Tatsuya
    Fukutomi, Akira
    Morizane, Chigusa
    Kasuga, Akiyoshi
    Takahashi, Hideaki
    Todaka, Akiko
    Okusaka, Takuji
    Creasy, Caretha L.
    Gorman, Shelby
    Felitsky, Daniel J.
    Kobayashi, Mikiro
    Zhang, Fanghong
    Furuse, Junji
    [J]. CANCER SCIENCE, 2018, 109 (01): : 215 - 224
  • [9] Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study
    Williams, Kerry J.
    Picus, Joel
    Trinkhaus, Kim
    Fournier, Chloe C.
    Suresh, Rama
    James, Joan S.
    Tan, Benjamin R.
    [J]. HPB, 2010, 12 (06) : 418 - 426
  • [10] Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers
    Tan, Elaine S.
    Cao, Biwei
    Kim, Jongphil
    Al-Toubah, Taymeyah E.
    Mehta, Rutika
    Centeno, Barbara A.
    Kim, Richard D.
    [J]. CANCER, 2021, 127 (08) : 1293 - 1300
12345